These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2179928)
21. Abnormal glutamate receptor expression in the medial temporal lobe in schizophrenia and mood disorders. Beneyto M; Kristiansen LV; Oni-Orisan A; McCullumsmith RE; Meador-Woodruff JH Neuropsychopharmacology; 2007 Sep; 32(9):1888-902. PubMed ID: 17299517 [TBL] [Abstract][Full Text] [Related]
22. NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder. Toro C; Deakin JF Schizophr Res; 2005 Dec; 80(2-3):323-30. PubMed ID: 16140506 [TBL] [Abstract][Full Text] [Related]
23. Platelet alpha-adrenergic receptor function in affective disorders and schizophrenia. Kafka MS; Siever LJ; Nurnberger JI; Uhde TW; Targum S; Cooper DM; van Kammen DP; Tokola NS Psychopharmacol Bull; 1985; 21(3):599-602. PubMed ID: 2994161 [No Abstract] [Full Text] [Related]
24. [Significance of GABA-energic system in the central nervous system in clinical psychologic medicine]. Ciu Z; Gao BL Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Aug; 23(4):249-51. PubMed ID: 2253516 [No Abstract] [Full Text] [Related]
25. Down-regulation of amygdala preprotachykinin A mRNA but not 3H-SP receptor binding sites in subjects affected by mood disorders and schizophrenia. Carletti R; Corsi M; Melotto S; Caberlotto L Eur J Neurosci; 2005 Mar; 21(6):1712-8. PubMed ID: 15845098 [TBL] [Abstract][Full Text] [Related]
26. Interactions between catecholamines and their receptors in blood. Ackenheil M; Bondy B; Fröhler M Clin Neuropharmacol; 1986; 9 Suppl 4():119-21. PubMed ID: 3032424 [No Abstract] [Full Text] [Related]
27. Ribosomal DNA transcription in dorsal raphe nucleus neurons is increased in residual schizophrenia compared to depressed patients with affective disorders. Krzyżanowska M; Steiner J; Brisch R; Mawrin C; Busse S; Braun K; Jankowski Z; Bernstein HG; Bogerts B; Gos T Psychiatry Res; 2015 Dec; 230(2):233-41. PubMed ID: 26350704 [TBL] [Abstract][Full Text] [Related]
28. Brain noradrenergic receptors in major depression and schizophrenia. Klimek V; Rajkowska G; Luker SN; Dilley G; Meltzer HY; Overholser JC; Stockmeier CA; Ordway GA Neuropsychopharmacology; 1999 Jul; 21(1):69-81. PubMed ID: 10379521 [TBL] [Abstract][Full Text] [Related]
29. Soluble NCAM. Secher T Adv Exp Med Biol; 2010; 663():227-42. PubMed ID: 20017026 [No Abstract] [Full Text] [Related]
30. GAD2 Alternative Transcripts in the Human Prefrontal Cortex, and in Schizophrenia and Affective Disorders. Davis KN; Tao R; Li C; Gao Y; Gondré-Lewis MC; Lipska BK; Shin JH; Xie B; Ye T; Weinberger DR; Kleinman JE; Hyde TM PLoS One; 2016; 11(2):e0148558. PubMed ID: 26848839 [TBL] [Abstract][Full Text] [Related]
31. Beta-adrenergic receptor function in affective illness. Pandey GN; Dysken MW; Garver DL; Davis JM Am J Psychiatry; 1979 May; 136(5):675-8. PubMed ID: 219719 [TBL] [Abstract][Full Text] [Related]
33. [Noradrenergic neurons, their interactions and the mechanism of affective disorders. Facts and hypotheses]. Kostowski W Psychiatr Pol; 1982; 16(1-2):1-11. PubMed ID: 6292977 [No Abstract] [Full Text] [Related]
34. An insertion/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders. Arinami T; Li L; Mitsushio H; Itokawa M; Hamaguchi H; Toru M Biol Psychiatry; 1996 Dec; 40(11):1122-7. PubMed ID: 8931914 [TBL] [Abstract][Full Text] [Related]
35. Central cholinergic-adrenergic imbalance in the regulation of affective state. Siever LJ; Risch SC; Murphy DL Psychiatry Res; 1981 Aug; 5(1):108-9. PubMed ID: 6944707 [No Abstract] [Full Text] [Related]
37. Glial fibrillary acidic protein and glutamine synthetase in subregions of prefrontal cortex in schizophrenia and mood disorder. Toro CT; Hallak JE; Dunham JS; Deakin JF Neurosci Lett; 2006 Sep; 404(3):276-81. PubMed ID: 16842914 [TBL] [Abstract][Full Text] [Related]
38. Alpha-adrenergic receptors and cyclic AMP production in a group of schizophrenic patients. Kafka MS; Kleinman JE; Karson CN; Wyatt RJ Hillside J Clin Psychiatry; 1986; 8(1):15-24. PubMed ID: 3017834 [TBL] [Abstract][Full Text] [Related]
39. The effectiveness of multi-target agents in schizophrenia and mood disorders: Relevance of receptor signature to clinical action. Wong EH; Tarazi FI; Shahid M Pharmacol Ther; 2010 May; 126(2):173-85. PubMed ID: 20171983 [TBL] [Abstract][Full Text] [Related]
40. Noradrenergic and corticosteroid receptors regulate somatic and motivational symptoms of morphine withdrawal. Solecki WB; Kus N; Gralec K; Klasa A; Pradel K; Przewłocki R Behav Brain Res; 2019 Mar; 360():146-157. PubMed ID: 30500430 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]